Hologic
HOLX
Market cap $14.4B

64.75 USD

-0.47

0.72%

At close Jun 13, 4:00 PM EDT

After hours

64.80

+0.05

0.08%

1 day

-0.72%

5 days

0.50%

1 month

13.36%

3 months

6.67%

6 months

-12.08%

Year to date

-9.74%

1 year

-10.24%

5 years

23.57%

10 years

74.62%

About: Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Employees: 7,063

Healthcare Medical Instruments & Supplies

0

Funds holding %

of 7,296 funds

0

Analysts bullish %

of 5 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

50% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 3 (+1) [Q1 2025]

3% less first-time investments, than exits

New positions opened: 100 | Existing positions closed: 103

9% less call options, than puts

Call options by funds: $19.2M | Put options by funds: $21.1M

2.46% less ownership

Funds ownership: 99.4% [Q4 2024] → 96.94% (-2.46%) [Q1 2025]

3% less funds holding

Funds holding: 706 [Q4 2024] → 686 (-20) [Q1 2025]

16% less repeat investments, than reductions

Existing positions increased: 229 | Existing positions reduced: 274

17% less capital invested

Capital invested by funds: $16.3B [Q4 2024] → $13.4B (-$2.83B) [Q1 2025]

See Fund Rankings

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$62

4%

downside

Avg. target

$68

4%

upside

High target

$71

10%

upside

5 analyst ratings

2 positive

40%

3 neutral

60%

0 negative

0%

Stephens & Co. Mason Carrico	8%upside $70	Overweight Maintained	13 May 2025
Morgan Stanley Tejas Savant	0%upside $65	Equal-Weight Maintained	5 May 2025
RBC Capital Conor McNamara	8%upside $70	Sector Perform Maintained	2 May 2025
Raymond James Andrew Cooper	10%upside $71	Outperform Reiterated	2 May 2025
Evercore ISI Group Vijay Kumar	4%downside $62	In-Line Maintained	2 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 12 articles about HOLX published over the past 30 days

Zacks Investment Research

Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?

HOLX grapples with global headwinds, but growth in Diagnostics and Breast Health service lifts confidence.

Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?

Zacks Investment Research

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Zacks Investment Research

Hologic Climbs 13% in a Month: How Should You Play the Stock?

After lagging for months, Hologic HOLX has picked up momentum in recent weeks. Shares of the Marlborough, MA-based company have climbed 13.3% over the past month, higher than the industry and the broader Medical sector's gains of 2.4% and 3.4%, respectively.

Hologic Climbs 13% in a Month: How Should You Play the Stock?

Zacks Investment Research

Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact?

HOLX weathers Breast Health softness with rising service revenues, the Endomag acquisition and new tech on the horizon.

Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact?

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

ARLINGTON, Va.--(BUSINESS WIRE)--NEST, an initiative of MDIC, is pleased to welcome Hologic, a leading global medical device company, to its Governance Committee.

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

Zacks Investment Research

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

Private equity firms TPG and Blackstone BX recently bid to acquire Hologic Inc. HOLX, valuing the U.S. medical technology company at over $16 billion.

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

Proactive Investors

Hologic reportedly rejects $16B go-private offer from TPG, Blackstone

TPG and Blackstone Inc (NYSE:BX), two private equity firms, have made a non-binding offer of more than $16 billion to take medical equipment-maker Hologic Inc (NASDAQ:HOLX) private, according to a media report from the Financial Times. Citing people with knowledge of the matter, the publication said Massachusetts-based Hologic has rejected the offer.

Hologic reportedly rejects $16B go-private offer from TPG, Blackstone

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

Medical equipment maker Hologic rejected a $16 billion non-binding offer from private equity firms TPG and Blackstone , the Financial Times reported on Tuesday, citing people familiar with the matter.

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

Zacks Investment Research

HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?

With women's health increasingly becoming a global priority, investors are actively targeting companies operating in this space to boost their portfolios. Research and Markets projects the women's health diagnostics market to expand at a compound annual rate of 9.25% through 2030, driven by technological advancements, increasing healthcare expenditures, and initiatives for early detection of women-specific conditions like reproductive health issues, breast cancer, osteoporosis and more.

HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?

See News Rankings

Charts implemented using Lightweight Charts™